5+
contributors before any chart is shown
100%
of published records de-identified
Contribute your story to the data.
The registry exists to turn scattered personal stories into structured, auditable longitudinal records. Contributions are standardized, versioned, and de-identified before anything is published.
Read the scope and boundaries
R3TA is an observational registry. We do not prescribe, recommend, assign, or direct the use of any compound. We record what contributors are already doing and how it is measured.
Complete the screening questionnaire
A short questionnaire confirms you are 18 or older, able to provide informed consent, and willing to submit standardized measurements on a regular cadence. No account is created until it is complete.
Give versioned consent
Consent is recorded with a version identifier (currently v1.0) and a timestamp. If the consent text changes, you are asked to re-consent before further collection.
Complete a baseline record
Demographic band, anthropometrics, activity level, prior exposure history, relevant history, and optional baseline laboratory values.
Submit structured check-ins
Weekly and monthly measurements, plus optional laboratory documents every 8–12 weeks. Each record stores its source, collection method, and verification state.
Withdraw whenever you choose
Withdrawal stops all further collection immediately. Already-published aggregate analyses cannot be recomputed retroactively, and this is disclosed before you consent.
Collection cadence
Weekly check-in
- — Weight
- — Appetite / satiety score
- — Energy score
- — Sleep quality and duration
- — Activity
- — Reported side effects or new symptoms
- — Exposure status / interruption
- — Optional free-text observation
Monthly check-in
- — Waist circumference
- — Body composition, if available
- — Blood pressure
- — Progress photography (optional, separately consented)
- — Quality-of-life measure
Every 8–12 weeks
- — Optional laboratory results from a third-party lab or clinician
- — Optional wearable summary
- — Extended safety and tolerability review
- — Continuation / discontinuation status
Open cohorts
What R3TA does not do
- — No dosing guidance, protocols, titration schedules, or treatment assignment.
- — No medical advice, diagnosis, or clinical care.
- — No claim that any compound is safe or effective for any condition.
- — No sale of participation, and no payment for data.
Interventional studies require a separate protocol, a named principal investigator, and independent ethics review. Those are handled outside this registry.